The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo-Reference-Cited by-同舟云学术

The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo

Published:2018-08 Issue:2 Volume:79 Page:369-371
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

van Geel Nanja,Bekkenk Marcel,Lommerts Janny E.,Ezzedine Khaled,Harris John,Hamzavi Iltefat,Eleftheriadou Viktoria,Picardo Mauro,Taieb Alain,Prinsen Cecilia A.C.,Wolkerstorfer Albert,Speeckaert Reinhart

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Development and validation of the Vitiligo Extent Score (VES): an international collaborative initiative;van Geel;J Invest Dermatol,2016

2. Meeting report: Vitiligo Global Issues Consensus Conference workshop “Outcome measurement instruments” and Vitiligo International Symposium, Rome, Nov 30-Dec 3;van Geel;Pigment Cell Melanoma Res,2017

3. Validation study of the Vitiligo Extent Score-plus (VESplus);van Geel;J Am Acad Dermatol,2017

4. Reproducibility and responsiveness of evaluative outcome measures. Theoretical considerations illustrated by an empirical example;de Vet;Int J Technol Assess Health Care,2001

5. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index;Hamzavi;Arch Dermatol,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Severity Strata of Disease Activity and Repigmentation in Vitiligo Based on Validated Physician Global Assessment (PGA) Scores;Journal of Clinical Medicine;2024-05-02

2. [Translated article] Quantification of the Progression Rate in Vitiligo and Prognostic Implications;Actas Dermo-Sifiliográficas;2024-05

3. Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized scleroderma Total Severity Scale (LoTSS);Arthritis Care & Research;2023-12-26

4. A meta‐analysis of the placebo response in vitiligo: Causes and consequences for the interpretation of clinical trials;Pigment Cell & Melanoma Research;2023-09-27

5. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm;Journal of the European Academy of Dermatology and Venereology;2023-09-25